Bio-Rad Laboratories, Inc. Class B

Go to Bio-Rad Laboratories, Inc. Class B Website

$247.05

0.00 (0.00%)
Live
Previous Close

$247.05

Day Range

$0 - $0

Previous Day Range

$0 - $0

Market Cap

$ USD

Day Vol.

0

Previous Day Vol.

0

Currency

USD

Primary Exchange

New York Stock Exchange

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and speci...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The North American Autoimmune Disease Diagnostics Market is projected to grow from $1.96 billion in 2024 to $3.5 billion by 2033, driven by rising autoimmune disease prevalence, technological advancements, and increased healthcare investments.

Related tickers: BIO, BIO.B, ABT, RHHBY, DGX, TMO.

Read Full Article

Global biochip market projected to grow from $16.1 billion in 2024 to $27.8 billion by 2029, with an 11.6% CAGR, driven by advances in diagnostics, genomics, and personalized medicine.

Related tickers: ABT, A, BIO, BIO.B, TMO, BMXXY.

Read Full Article
Trending Tickers

Please sign in to view